That campaign brag sheet is about to get substantially bigger.

“The first negotiations will be over 10 drugs selected by the administration, including blood thinners #Eliquis and #Xarelto and the diabetes drugs #Jardiance and #Januvia. The lower prices for those drugs are scheduled to go into effect at the beginning of 2026. Other drugs will be negotiated in the years that follow.”

#medication #pharmaceuticals #medicine #drugs

https://www.nytimes.com/2023/10/03/us/politics/drug-makers-negotiate-prices-medicare.html

#Biden administration names 10 #PrescriptionDrugs for #PriceNegotiations

1. #Eliquis, a #BloodThinner;
2. #Jardiance, which treats #diabetes & #HeartFailure;
3. #Xarelto, another #BloodThinner.
4. 5. & 6. #Januvia, #Farxiga & #NovoLog, treat #diabetes among other conditions;
7. & 8. #Enbrel & #Stelara, for #arthritis & #psoriasis;
9. #Entresto, for #HeartFailure; &
10. #Imbruvica, for #cancers of the #blood.

https://www.washingtonpost.com/health/2023/08/29/medicare-drug-price-negotiations/

Why this didn't happen earlier?

Because the #Pharmaceutical Lobby pulled all the strings possible to avoid it!

“President #Biden signed the #InflationReductionAct of 2022 into law and for the FIRST time, the law provides #Medicare the ability to directly negotiate the prices of certain high expenditure, single source drugs without generic or biosimilar competition”

#eliuis #Jardiance #Xarelto #januvia #PartD
https://www.cms.gov/files/document/fact-sheet-medicare-selected-drug-negotiation-list-ipay-2026.pdf